Tumor Ablation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Cryoablation, Radiofrequency (RF) Ablation, Microwave Ablation and Others), Application (Lung Cancer, Liver Cancer, Kidney Cancer, Bone Metastasis and Others), Mode of Treatment (Percutaneous Ablation, Surgical Ablation, Laparoscopic Ablation, Others), and Geography
Report Code: TIPHE100001314 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET OVERVIEW
:
Tumor ablation is a minimally invasive procedure for treating liver, kidney, bone, and lung cancers. Thermal energy is utilized to heat or cool tissue to cytotoxic levels during tumor ablation. Many patients with minor hepatocellular carcinomas or benign tumors in the liver are considering ablation as a first-line treatment. Tumor ablation is a minimally invasive surgical procedure for the treatment of solid tumours. Without the need for surgery, special probes are utilised to "burn" or "freeze" tumours. The needle probe is guided and positioned into the tumour using computed tomography (CT), ultrasound (US), or magnetic resonance imaging (MRI).
MARKET SCOPE
The "Tumor Ablation Market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Tumor Ablation Market with detailed market segmentation by of Type, Application, Source and End Users. The Tumor Ablation Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Tumor Ablation Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- n the basis of Technology, the market is segmented into Cryoablation, Radiofrequency (RF) Ablation, Microwave Ablation and Others.
- n the basis of Application, the market is segmented into Lung Cancer, Liver Cancer, Kidney Cancer, Bone Metastasis and Others.
- n the basis of Treatment, the market is segmented into Percutaneous Ablation, Surgical Ablation, Laparoscopic Ablation, Others.
MARKET DYNAMICS
Drivers
- Rising geriatric population, increasing prevalence of cancer would be an important factor to drive the market for pressure devices.
- In addition, Various technological advancements in the healthcare business in Asia Pacific and Europe are projected to provide chances for market to offer growth opportunities for tumor ablation market.
Restraints
In the projection period, a lack of awareness about the indicators of Cancer and a lack of financial aid for the poor could hinder the market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Tumor Ablation Marketbased on various segments. It also provides market size and forecast estimates from year 2017 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Tumor Ablation Marketby each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Tumor Ablation Marketfrom both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Tumor Ablation Market in these regions.
IMPACT OF COVID-19 ON CELL SEPARATION SYSTEMS MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the Tumor Ablation Market in 2020.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Tumor Ablation Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Tumor Ablation Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Tumor Ablation Market in the global market. Below mentioned is the list of few companies engaged in the Cell Separation Systems Market.
The report also includes the profiles of key players in Tumor Ablation Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tumor Ablation Market - By Technology
1.3.2 Tumor Ablation Market - By Application
1.3.3 Tumor Ablation Market - By Treatment
1.3.4 Tumor Ablation Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TUMOR ABLATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TUMOR ABLATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TUMOR ABLATION MARKET - GLOBAL MARKET ANALYSIS
6.1. TUMOR ABLATION - GLOBAL MARKET OVERVIEW
6.2. TUMOR ABLATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. CRYOABLATION
7.3.1. Overview
7.3.2. Cryoablation Market Forecast and Analysis
7.4. RADIOFREQUENCY (RF) ABLATION
7.4.1. Overview
7.4.2. Radiofrequency (RF) Ablation Market Forecast and Analysis
7.5. MICROWAVE ABLATION
7.5.1. Overview
7.5.2. Microwave Ablation Market Forecast and Analysis
7.6. STEREOTACTIC BODY RADIOTHERAPY (SBRT)
7.6.1. Overview
7.6.2. Stereotactic Body Radiotherapy (SBRT) Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. LUNG CANCER
8.3.1. Overview
8.3.2. Lung Cancer Market Forecast and Analysis
8.4. LIVER CANCER
8.4.1. Overview
8.4.2. Liver Cancer Market Forecast and Analysis
8.5. KIDNEY CANCER
8.5.1. Overview
8.5.2. Kidney Cancer Market Forecast and Analysis
8.6. BONE METASTASIS
8.6.1. Overview
8.6.2. Bone Metastasis Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. PERCUTANEOUS ABLATION
9.3.1. Overview
9.3.2. Percutaneous Ablation Market Forecast and Analysis
9.4. SURGICAL ABLATION
9.4.1. Overview
9.4.2. Surgical Ablation Market Forecast and Analysis
9.5. LAPAROSCOPIC ABLATION
9.5.1. Overview
9.5.2. Laparoscopic Ablation Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Tumor Ablation Market Overview
10.1.2 North America Tumor Ablation Market Forecasts and Analysis
10.1.3 North America Tumor Ablation Market Forecasts and Analysis - By Technology
10.1.4 North America Tumor Ablation Market Forecasts and Analysis - By Application
10.1.5 North America Tumor Ablation Market Forecasts and Analysis - By Treatment
10.1.6 North America Tumor Ablation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Tumor Ablation Market
10.1.6.1.1 United States Tumor Ablation Market by Technology
10.1.6.1.2 United States Tumor Ablation Market by Application
10.1.6.1.3 United States Tumor Ablation Market by Treatment
10.1.6.2 Canada Tumor Ablation Market
10.1.6.2.1 Canada Tumor Ablation Market by Technology
10.1.6.2.2 Canada Tumor Ablation Market by Application
10.1.6.2.3 Canada Tumor Ablation Market by Treatment
10.1.6.3 Mexico Tumor Ablation Market
10.1.6.3.1 Mexico Tumor Ablation Market by Technology
10.1.6.3.2 Mexico Tumor Ablation Market by Application
10.1.6.3.3 Mexico Tumor Ablation Market by Treatment
10.2. EUROPE
10.2.1 Europe Tumor Ablation Market Overview
10.2.2 Europe Tumor Ablation Market Forecasts and Analysis
10.2.3 Europe Tumor Ablation Market Forecasts and Analysis - By Technology
10.2.4 Europe Tumor Ablation Market Forecasts and Analysis - By Application
10.2.5 Europe Tumor Ablation Market Forecasts and Analysis - By Treatment
10.2.6 Europe Tumor Ablation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Tumor Ablation Market
10.2.6.1.1 Germany Tumor Ablation Market by Technology
10.2.6.1.2 Germany Tumor Ablation Market by Application
10.2.6.1.3 Germany Tumor Ablation Market by Treatment
10.2.6.2 France Tumor Ablation Market
10.2.6.2.1 France Tumor Ablation Market by Technology
10.2.6.2.2 France Tumor Ablation Market by Application
10.2.6.2.3 France Tumor Ablation Market by Treatment
10.2.6.3 Italy Tumor Ablation Market
10.2.6.3.1 Italy Tumor Ablation Market by Technology
10.2.6.3.2 Italy Tumor Ablation Market by Application
10.2.6.3.3 Italy Tumor Ablation Market by Treatment
10.2.6.4 Spain Tumor Ablation Market
10.2.6.4.1 Spain Tumor Ablation Market by Technology
10.2.6.4.2 Spain Tumor Ablation Market by Application
10.2.6.4.3 Spain Tumor Ablation Market by Treatment
10.2.6.5 United Kingdom Tumor Ablation Market
10.2.6.5.1 United Kingdom Tumor Ablation Market by Technology
10.2.6.5.2 United Kingdom Tumor Ablation Market by Application
10.2.6.5.3 United Kingdom Tumor Ablation Market by Treatment
10.2.6.6 Rest of Europe Tumor Ablation Market
10.2.6.6.1 Rest of Europe Tumor Ablation Market by Technology
10.2.6.6.2 Rest of Europe Tumor Ablation Market by Application
10.2.6.6.3 Rest of Europe Tumor Ablation Market by Treatment
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Tumor Ablation Market Overview
10.3.2 Asia-Pacific Tumor Ablation Market Forecasts and Analysis
10.3.3 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Treatment
10.3.6 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Tumor Ablation Market
10.3.6.1.1 Australia Tumor Ablation Market by Technology
10.3.6.1.2 Australia Tumor Ablation Market by Application
10.3.6.1.3 Australia Tumor Ablation Market by Treatment
10.3.6.2 China Tumor Ablation Market
10.3.6.2.1 China Tumor Ablation Market by Technology
10.3.6.2.2 China Tumor Ablation Market by Application
10.3.6.2.3 China Tumor Ablation Market by Treatment
10.3.6.3 India Tumor Ablation Market
10.3.6.3.1 India Tumor Ablation Market by Technology
10.3.6.3.2 India Tumor Ablation Market by Application
10.3.6.3.3 India Tumor Ablation Market by Treatment
10.3.6.4 Japan Tumor Ablation Market
10.3.6.4.1 Japan Tumor Ablation Market by Technology
10.3.6.4.2 Japan Tumor Ablation Market by Application
10.3.6.4.3 Japan Tumor Ablation Market by Treatment
10.3.6.5 South Korea Tumor Ablation Market
10.3.6.5.1 South Korea Tumor Ablation Market by Technology
10.3.6.5.2 South Korea Tumor Ablation Market by Application
10.3.6.5.3 South Korea Tumor Ablation Market by Treatment
10.3.6.6 Rest of Asia-Pacific Tumor Ablation Market
10.3.6.6.1 Rest of Asia-Pacific Tumor Ablation Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Tumor Ablation Market by Application
10.3.6.6.3 Rest of Asia-Pacific Tumor Ablation Market by Treatment
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Tumor Ablation Market Overview
10.4.2 Middle East and Africa Tumor Ablation Market Forecasts and Analysis
10.4.3 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Treatment
10.4.6 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Tumor Ablation Market
10.4.6.1.1 South Africa Tumor Ablation Market by Technology
10.4.6.1.2 South Africa Tumor Ablation Market by Application
10.4.6.1.3 South Africa Tumor Ablation Market by Treatment
10.4.6.2 Saudi Arabia Tumor Ablation Market
10.4.6.2.1 Saudi Arabia Tumor Ablation Market by Technology
10.4.6.2.2 Saudi Arabia Tumor Ablation Market by Application
10.4.6.2.3 Saudi Arabia Tumor Ablation Market by Treatment
10.4.6.3 U.A.E Tumor Ablation Market
10.4.6.3.1 U.A.E Tumor Ablation Market by Technology
10.4.6.3.2 U.A.E Tumor Ablation Market by Application
10.4.6.3.3 U.A.E Tumor Ablation Market by Treatment
10.4.6.4 Turkey Tumor Ablation Market
10.4.6.4.1 Turkey Tumor Ablation Market by Technology
10.4.6.4.2 Turkey Tumor Ablation Market by Application
10.4.6.4.3 Turkey Tumor Ablation Market by Treatment
10.4.6.5 Rest of Middle East and Africa Tumor Ablation Market
10.4.6.5.1 Rest of Middle East and Africa Tumor Ablation Market by Technology
10.4.6.5.2 Rest of Middle East and Africa Tumor Ablation Market by Application
10.4.6.5.3 Rest of Middle East and Africa Tumor Ablation Market by Treatment
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Tumor Ablation Market Overview
10.5.2 South and Central America Tumor Ablation Market Forecasts and Analysis
10.5.3 South and Central America Tumor Ablation Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Tumor Ablation Market Forecasts and Analysis - By Application
10.5.5 South and Central America Tumor Ablation Market Forecasts and Analysis - By Treatment
10.5.6 South and Central America Tumor Ablation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Tumor Ablation Market
10.5.6.1.1 Brazil Tumor Ablation Market by Technology
10.5.6.1.2 Brazil Tumor Ablation Market by Application
10.5.6.1.3 Brazil Tumor Ablation Market by Treatment
10.5.6.2 Argentina Tumor Ablation Market
10.5.6.2.1 Argentina Tumor Ablation Market by Technology
10.5.6.2.2 Argentina Tumor Ablation Market by Application
10.5.6.2.3 Argentina Tumor Ablation Market by Treatment
10.5.6.3 Rest of South and Central America Tumor Ablation Market
10.5.6.3.1 Rest of South and Central America Tumor Ablation Market by Technology
10.5.6.3.2 Rest of South and Central America Tumor Ablation Market by Application
10.5.6.3.3 Rest of South and Central America Tumor Ablation Market by Treatment
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUMOR ABLATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. TUMOR ABLATION MARKET, KEY COMPANY PROFILES
13.1. HEALTHTRONICS, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BOSTON SCIENTIFIC CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MISONIX, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERMAID MEDICAL A/S
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NEUWAVE MEDICAL, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEDTRONIC, PLC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ANGIODYNAMICS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GALIL MEDICAL, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. EDAP TMS S.A.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SONACARE MEDICAL LLC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tumor Ablation Market - By Technology
1.3.2 Tumor Ablation Market - By Application
1.3.3 Tumor Ablation Market - By Treatment
1.3.4 Tumor Ablation Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TUMOR ABLATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TUMOR ABLATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TUMOR ABLATION MARKET - GLOBAL MARKET ANALYSIS
6.1. TUMOR ABLATION - GLOBAL MARKET OVERVIEW
6.2. TUMOR ABLATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. CRYOABLATION
7.3.1. Overview
7.3.2. Cryoablation Market Forecast and Analysis
7.4. RADIOFREQUENCY (RF) ABLATION
7.4.1. Overview
7.4.2. Radiofrequency (RF) Ablation Market Forecast and Analysis
7.5. MICROWAVE ABLATION
7.5.1. Overview
7.5.2. Microwave Ablation Market Forecast and Analysis
7.6. STEREOTACTIC BODY RADIOTHERAPY (SBRT)
7.6.1. Overview
7.6.2. Stereotactic Body Radiotherapy (SBRT) Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. LUNG CANCER
8.3.1. Overview
8.3.2. Lung Cancer Market Forecast and Analysis
8.4. LIVER CANCER
8.4.1. Overview
8.4.2. Liver Cancer Market Forecast and Analysis
8.5. KIDNEY CANCER
8.5.1. Overview
8.5.2. Kidney Cancer Market Forecast and Analysis
8.6. BONE METASTASIS
8.6.1. Overview
8.6.2. Bone Metastasis Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. PERCUTANEOUS ABLATION
9.3.1. Overview
9.3.2. Percutaneous Ablation Market Forecast and Analysis
9.4. SURGICAL ABLATION
9.4.1. Overview
9.4.2. Surgical Ablation Market Forecast and Analysis
9.5. LAPAROSCOPIC ABLATION
9.5.1. Overview
9.5.2. Laparoscopic Ablation Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Tumor Ablation Market Overview
10.1.2 North America Tumor Ablation Market Forecasts and Analysis
10.1.3 North America Tumor Ablation Market Forecasts and Analysis - By Technology
10.1.4 North America Tumor Ablation Market Forecasts and Analysis - By Application
10.1.5 North America Tumor Ablation Market Forecasts and Analysis - By Treatment
10.1.6 North America Tumor Ablation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Tumor Ablation Market
10.1.6.1.1 United States Tumor Ablation Market by Technology
10.1.6.1.2 United States Tumor Ablation Market by Application
10.1.6.1.3 United States Tumor Ablation Market by Treatment
10.1.6.2 Canada Tumor Ablation Market
10.1.6.2.1 Canada Tumor Ablation Market by Technology
10.1.6.2.2 Canada Tumor Ablation Market by Application
10.1.6.2.3 Canada Tumor Ablation Market by Treatment
10.1.6.3 Mexico Tumor Ablation Market
10.1.6.3.1 Mexico Tumor Ablation Market by Technology
10.1.6.3.2 Mexico Tumor Ablation Market by Application
10.1.6.3.3 Mexico Tumor Ablation Market by Treatment
10.2. EUROPE
10.2.1 Europe Tumor Ablation Market Overview
10.2.2 Europe Tumor Ablation Market Forecasts and Analysis
10.2.3 Europe Tumor Ablation Market Forecasts and Analysis - By Technology
10.2.4 Europe Tumor Ablation Market Forecasts and Analysis - By Application
10.2.5 Europe Tumor Ablation Market Forecasts and Analysis - By Treatment
10.2.6 Europe Tumor Ablation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Tumor Ablation Market
10.2.6.1.1 Germany Tumor Ablation Market by Technology
10.2.6.1.2 Germany Tumor Ablation Market by Application
10.2.6.1.3 Germany Tumor Ablation Market by Treatment
10.2.6.2 France Tumor Ablation Market
10.2.6.2.1 France Tumor Ablation Market by Technology
10.2.6.2.2 France Tumor Ablation Market by Application
10.2.6.2.3 France Tumor Ablation Market by Treatment
10.2.6.3 Italy Tumor Ablation Market
10.2.6.3.1 Italy Tumor Ablation Market by Technology
10.2.6.3.2 Italy Tumor Ablation Market by Application
10.2.6.3.3 Italy Tumor Ablation Market by Treatment
10.2.6.4 Spain Tumor Ablation Market
10.2.6.4.1 Spain Tumor Ablation Market by Technology
10.2.6.4.2 Spain Tumor Ablation Market by Application
10.2.6.4.3 Spain Tumor Ablation Market by Treatment
10.2.6.5 United Kingdom Tumor Ablation Market
10.2.6.5.1 United Kingdom Tumor Ablation Market by Technology
10.2.6.5.2 United Kingdom Tumor Ablation Market by Application
10.2.6.5.3 United Kingdom Tumor Ablation Market by Treatment
10.2.6.6 Rest of Europe Tumor Ablation Market
10.2.6.6.1 Rest of Europe Tumor Ablation Market by Technology
10.2.6.6.2 Rest of Europe Tumor Ablation Market by Application
10.2.6.6.3 Rest of Europe Tumor Ablation Market by Treatment
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Tumor Ablation Market Overview
10.3.2 Asia-Pacific Tumor Ablation Market Forecasts and Analysis
10.3.3 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Treatment
10.3.6 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Tumor Ablation Market
10.3.6.1.1 Australia Tumor Ablation Market by Technology
10.3.6.1.2 Australia Tumor Ablation Market by Application
10.3.6.1.3 Australia Tumor Ablation Market by Treatment
10.3.6.2 China Tumor Ablation Market
10.3.6.2.1 China Tumor Ablation Market by Technology
10.3.6.2.2 China Tumor Ablation Market by Application
10.3.6.2.3 China Tumor Ablation Market by Treatment
10.3.6.3 India Tumor Ablation Market
10.3.6.3.1 India Tumor Ablation Market by Technology
10.3.6.3.2 India Tumor Ablation Market by Application
10.3.6.3.3 India Tumor Ablation Market by Treatment
10.3.6.4 Japan Tumor Ablation Market
10.3.6.4.1 Japan Tumor Ablation Market by Technology
10.3.6.4.2 Japan Tumor Ablation Market by Application
10.3.6.4.3 Japan Tumor Ablation Market by Treatment
10.3.6.5 South Korea Tumor Ablation Market
10.3.6.5.1 South Korea Tumor Ablation Market by Technology
10.3.6.5.2 South Korea Tumor Ablation Market by Application
10.3.6.5.3 South Korea Tumor Ablation Market by Treatment
10.3.6.6 Rest of Asia-Pacific Tumor Ablation Market
10.3.6.6.1 Rest of Asia-Pacific Tumor Ablation Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Tumor Ablation Market by Application
10.3.6.6.3 Rest of Asia-Pacific Tumor Ablation Market by Treatment
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Tumor Ablation Market Overview
10.4.2 Middle East and Africa Tumor Ablation Market Forecasts and Analysis
10.4.3 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Treatment
10.4.6 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Tumor Ablation Market
10.4.6.1.1 South Africa Tumor Ablation Market by Technology
10.4.6.1.2 South Africa Tumor Ablation Market by Application
10.4.6.1.3 South Africa Tumor Ablation Market by Treatment
10.4.6.2 Saudi Arabia Tumor Ablation Market
10.4.6.2.1 Saudi Arabia Tumor Ablation Market by Technology
10.4.6.2.2 Saudi Arabia Tumor Ablation Market by Application
10.4.6.2.3 Saudi Arabia Tumor Ablation Market by Treatment
10.4.6.3 U.A.E Tumor Ablation Market
10.4.6.3.1 U.A.E Tumor Ablation Market by Technology
10.4.6.3.2 U.A.E Tumor Ablation Market by Application
10.4.6.3.3 U.A.E Tumor Ablation Market by Treatment
10.4.6.4 Turkey Tumor Ablation Market
10.4.6.4.1 Turkey Tumor Ablation Market by Technology
10.4.6.4.2 Turkey Tumor Ablation Market by Application
10.4.6.4.3 Turkey Tumor Ablation Market by Treatment
10.4.6.5 Rest of Middle East and Africa Tumor Ablation Market
10.4.6.5.1 Rest of Middle East and Africa Tumor Ablation Market by Technology
10.4.6.5.2 Rest of Middle East and Africa Tumor Ablation Market by Application
10.4.6.5.3 Rest of Middle East and Africa Tumor Ablation Market by Treatment
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Tumor Ablation Market Overview
10.5.2 South and Central America Tumor Ablation Market Forecasts and Analysis
10.5.3 South and Central America Tumor Ablation Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Tumor Ablation Market Forecasts and Analysis - By Application
10.5.5 South and Central America Tumor Ablation Market Forecasts and Analysis - By Treatment
10.5.6 South and Central America Tumor Ablation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Tumor Ablation Market
10.5.6.1.1 Brazil Tumor Ablation Market by Technology
10.5.6.1.2 Brazil Tumor Ablation Market by Application
10.5.6.1.3 Brazil Tumor Ablation Market by Treatment
10.5.6.2 Argentina Tumor Ablation Market
10.5.6.2.1 Argentina Tumor Ablation Market by Technology
10.5.6.2.2 Argentina Tumor Ablation Market by Application
10.5.6.2.3 Argentina Tumor Ablation Market by Treatment
10.5.6.3 Rest of South and Central America Tumor Ablation Market
10.5.6.3.1 Rest of South and Central America Tumor Ablation Market by Technology
10.5.6.3.2 Rest of South and Central America Tumor Ablation Market by Application
10.5.6.3.3 Rest of South and Central America Tumor Ablation Market by Treatment
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUMOR ABLATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. TUMOR ABLATION MARKET, KEY COMPANY PROFILES
13.1. HEALTHTRONICS, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BOSTON SCIENTIFIC CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MISONIX, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERMAID MEDICAL A/S
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NEUWAVE MEDICAL, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEDTRONIC, PLC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ANGIODYNAMICS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GALIL MEDICAL, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. EDAP TMS S.A.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SONACARE MEDICAL LLC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. HEALTHTRONICS, INC.
2. BOSTON SCIENTIFIC CORPORATION
3. MISONIX, INC.
4. MERMAID MEDICAL A/S
5. NEUWAVE MEDICAL, INC.
6. MEDTRONIC, PLC
7. ANGIODYNAMICS, INC.
8. GALIL MEDICAL, INC.
9. EDAP TMS S.A.
10. SONACARE MEDICAL LLC
11. STARmed
12. RF Medical
13. Olympus
14. Johnson and Johnson
15. Surgnova Healthcare Technologies
16. ECHO Microwave
1. HEALTHTRONICS, INC.
2. BOSTON SCIENTIFIC CORPORATION
3. MISONIX, INC.
4. MERMAID MEDICAL A/S
5. NEUWAVE MEDICAL, INC.
6. MEDTRONIC, PLC
7. ANGIODYNAMICS, INC.
8. GALIL MEDICAL, INC.
9. EDAP TMS S.A.
10. SONACARE MEDICAL LLC
11. STARmed
12. RF Medical
13. Olympus
14. Johnson and Johnson
15. Surgnova Healthcare Technologies
16. ECHO Microwave
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
GET FREE SAMPLE PDF
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount